|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1992-6-12
|
|
pubmed:abstractText |
We report a case of primary localized amyloidosis of the bladder with amyloid deposits which was characterized as being of immunoglobulin light chain origin (AL) including lambda type (A lambda) and P component (AP) using the KMnO4 pretreatment method and immunohistochemical procedures. The patient was treated successfully with intravesical dimethyl sulfoxide instillation and oral administration of high-dose cepharanthin after transurethral resection. Combination therapy with dimethyl sulfoxide and cepharanthin was shown to be useful for primary localized amyloidosis of the bladder.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0042-1138
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
228-31
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:1585522-Aged,
pubmed-meshheading:1585522-Alkaloids,
pubmed-meshheading:1585522-Amyloid,
pubmed-meshheading:1585522-Amyloidosis,
pubmed-meshheading:1585522-Anti-Inflammatory Agents,
pubmed-meshheading:1585522-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:1585522-Benzylisoquinolines,
pubmed-meshheading:1585522-Dimethyl Sulfoxide,
pubmed-meshheading:1585522-Drug Therapy, Combination,
pubmed-meshheading:1585522-Female,
pubmed-meshheading:1585522-Humans,
pubmed-meshheading:1585522-Urinary Bladder,
pubmed-meshheading:1585522-Urinary Bladder Diseases
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Primary localized amyloidosis of the bladder: a case of AL (lambda) amyloid protein and combination therapy using dimethyl sulfoxide and cepharanthin.
|
|
pubmed:affiliation |
Department of Urology, Niigata University School of Medicine, Japan.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
